Please provide your email address to receive an email when new articles are posted on . Oculis will acquire all worldwide rights to privosegtor from Accure Therapeutics. Privosegtor is being ...
Multiple sclerosis (MS) is the most common chronic autoimmune disease of the central nervous system. An early and accurate diagnosis is crucial for improving the effectiveness of treatment and ...
Transaction will enhance Oculis’ strategic flexibility and ownership of Privosegtor while driving long-term value creationTransaction ...
In this episode of NeuroOp Guru in collaboration with Ophthalmology Times, host Andrew G. Lee, MD, is joined by Drew Carey, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results